v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (20,427) $ (44,027)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4,569 4,227
Amortization of right-of-use assets 287 609
Amortization of contract costs to obtain 65 87
Amortization of contract costs to fulfill 335 168
Amortization of deferred financing fees 1,944 673
Stock-based compensation 1,504 2,359
Bad debt expense 92 735
Gain on derecognition of right-of-use asset and lease liabilities (96)  
Foreign currency loss (gain) 27 (52)
Investments interest receivable, amortization and accretion (27) (950)
Loss on debt extinguishment 0 1,405
Loss on divestiture 0 3,290
Loss on disposal of property, equipment and software 34 191
Change in fair value of derivative liability and contingent consideration 40 (1,692)
Noncash interest expense 3,605 6,276
Paid-in-kind interest capitalized 6,894  
Income from equity method investment (205) 0
Changes in operating assets and liabilities:    
Accounts receivable 898 9,212
Prepaid expenses and other current assets 262 (776)
Other assets (215) (167)
Accounts payable (390) (1,402)
Accrued expenses 1,591 (5,477)
Deferred revenue (59) (90)
Lease liabilities (293) (825)
Long-term liabilities (7,798) (4,560)
Net cash used in operating activities (7,363) (30,786)
Cash flows from investing activities:    
Purchases of property, equipment and software (154) (1,578)
Investment in capitalized software (5,005) (5,447)
Proceeds from sale of marketable securities 0 32,305
Divested cash 0 (580)
Net cash provided by (used in) investing activities (5,159) 24,700
Cash flows from financing activities:    
Repayment of long-term debt (10,000) (17,500)
Payments of deferred financing fees (2,569) (566)
Proceeds from revolving credit facility 120,388  
Payments on revolving credit facility (107,099) 0
Proceeds from issuance of common stock, net 2,912  
Net cash provided by (used in) financing activities 3,632 (18,066)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 0 75
Net decrease in cash, cash equivalents and restricted cash (8,890) (24,077)
Cash, cash equivalents and restricted cash, beginning of year 14,179 38,256
Cash, cash equivalents and restricted cash, end of year 5,289 14,179
Supplemental disclosure of cash flow information:    
Cash paid for interest 1,159 7,172
Cash paid for income taxes 9 $ 560
Supplemental noncash investing and financing activities:    
Issuance of common stock in connection with term loan amendment $ 1,287